Healthcare -
Biotechnology - NASDAQ - US
$ 20.72
-1.57 %
$ 1.8 B
Market Cap
-4.58
P/E
TVTX - PRE-TAX INCOME
Pre-tax Income TVTX - Travere Therapeutics, Inc.
-376 M
LAST VALUE
-44.68%
2 YEAR CAGR
-29.85%
5 YEAR CAGR
-27.26%
10 YEAR CAGR